Study Finds Immune System Can Cause Reaction to ImClone Systems Incorporated Cancer Drug

WASHINGTON (Reuters) - People who live in parts of the U.S. south may have pre-existing immunities that cause a severe allergic reaction to the cancer drug Erbitux, U.S. researchers reported on Thursday.